Oncology (ONC) Community

Provide forums for interactions of Community members to foster new relationships and provide interactive scientific discussion on current key issues in oncology.
Develop of best practices for Annual Meeting scientific programming proposals that leads to scientifically rich, well-developed collaborative proposals issues in oncology.
Utilize social media to post impactful publications or presentations, permit commentary, and promote discussion among members.
Standardize criteria to prioritize scientific proposals in collaboration with members of other Communities housed within the Translational & Precision Network.

The webinars below can be accessed in the Members Only Webinar Library: Access Library

Minimum Anticipated Biological Effect Level (MABEL) for Selection of First-in-Human (FIH) Starting Dose of Immune-Activating Biotherapeutics Description (Part 2 of 2)
Recent Perspectives and Advances on the Development of Cell Therapies for Cancer
Clinical Trials in the Pediatric CKD Population: Challenges and Opportunities
A Semi-Mechanistic PK/PD Model to Project Undetectable Minimal Residual Disease Rates in Chronic Lymphocytic Leukemia Studies
Translational and Clinical Pharmacology Considerations in the Development of Immune Oncology Drugs (Encore Presentation)
Convergence of Therapeutic Approaches in Oncology and HIV to Target Immune Evasion: Integrating Clinical Pharmacology Lessons Learned
Using Preclinical Data in Phase I Oncology Trials: A Bayesian Decision Theoretic Approach
Translational and Clinical Pharmacology Considerations in the Development of Immune Oncology Drugs
IQ CPLG PWG: Strategies to Address Opportunities in Oncology Pediatric Drug
Clinical Pharmacological and Pharmacodynamic Perspectives on the Adverse Events of Cancer Immunotherapy